Novartis AG is 137.5x more valuable than Pharvaris N.V. by market capitalization ($282.64 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PHVS | NVS |
|---|---|---|
| Market cap | $2.05 B | $282.64 B |
| US-listed rank | #2084 | #47 |
| SEC filings | 254 | 947 |
Novartis AG is 137.5x more valuable than Pharvaris N.V. by market capitalization ($282.64 B vs $2.05 B).
Full pages: Pharvaris N.V. and Novartis AG, or browse the full rankings.